Shanghai Haohai Biological details H-share repurchase activity

Shanghai Haohai Biological Technology Co., Ltd. announced its H-share repurchase activities for November 26, 2025. The company repurchased 155,700 H-shares on the Hong Kong Stock Exchange at prices ranging from HK$27.54 to HK$28, totaling HK$4,326,132. These repurchased shares represent 0.0681% of the existing H-shares before the event. The company's total issued H-shares (excluding treasury shares) stood at 38,529,240, with no treasury shares held, following this transaction.

The disclosure also covered A-share activity, where the total issued A-shares (excluding treasury shares) remained unchanged at 190,203,760, with 3,848,095 treasury A-shares, bringing the total issued shares to 194,051,855.

The latest repurchase on November 26, 2025, is part of a broader buyback authorization approved on June 10, 2025. Under this authorization, the company has cumulatively repurchased 1,558,300 H-shares, representing 3.9812% of the issued shares at the time the authorization was passed. The temporary halt period for new share issuance, re-sale, or transfer of treasury shares following this repurchase is until December 26, 2025.